OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE (AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE) — FDA Approval ANDA210718 (PIR
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE (AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE) — FDA Approval ANDA210718 (PIR is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE; Active ingredients: AMLODIPINE BESYLATE; HYD
| Brand name | OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL |
| Application number | ANDA210718 |
| Sponsor | PIRAMAL |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 5 |
| First approval date | 20250514 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →